Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Ostrava-Poruba
Clinical trial register · Czechia

Clinical Trials in Ostrava-Poruba, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Czechia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1522 matching records held by the registry are in this view. Synced 14 Nov 2026, 03:18 UTC
1522
Studies in scope
all four open statuses
785
Recruiting now
open to new participants
303
Lead sponsors
across recruiting studies
Top sites
Prague 1087 Brno 612 Hradec Králové 324 Olomouc 315 Ostrava 285

Trials with a site in Ostrava-Poruba

72 of 1522 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Czechia
Start
Recruiting
Faron Pharmaceuticals Ltd
Phase 2
90
Brno, Hradec Králové, Ostrava-Poruba, Prague
2026-11
Recruiting
Incyte Corporation
Phase 3
426
Brno, Ostrava-poruba, Prague
2026-09-08
Recruiting
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
NCT07625644Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma, Sclc
SystImmune Inc.
Phase 3
550
České Budějovice, Ostrava, Ostrava-Poruba, Prague
2026-08-04
Recruiting
Amgen
Phase 3
304
Náchod, Ostrava - Poruba, Prague, Mladá Boleslav
2026-05-27
Recruiting
Janssen Research & Development, LLC
Phase 3
530
Brno, Hradec Kralova, Hradec Králové, Ostrava-Poruba, Prague
2026-04-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
900
Brno, Ostrava-Poruba, Hradec Králové, Prague
2026-02-16
Active, closed
Amgen
Phase 3
250
Benesov U Prahy, Brno, Ostrava - Poruba
2025-12-19
Active, closed
Amgen
Phase 3
250
Benesov U Prahy, Brno, Ostrava - Poruba
2025-11-25
Recruiting
Fresenius Medical Care Deutschland GmbH
Not applicable
43
Ostrava-Poruba
2025-10-20
Recruiting
Novo Nordisk A/S
Phase 3
1,280
Broumov, Brno, Olomouc, Ostrava-Poruba, Prague, Uherské Hradiště
2025-10-02
Recruiting
Kura Oncology, Inc.
Phase 3
1,300
Ostrava-Poruba, Prague
2025-09-26
Recruiting
Boehringer Ingelheim
Phase 2
300
Hradec Králové, Ostrava-Poruba, Pardubice, Prague
2025-06-05
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Brno, Hradec Králové, Ostrava - Poruba, Pilsen, Prague
2025-06-04
Active, closed
Incyte Corporation
Phase 3
9
Hradec Králové, Ostrava-poruba, Prague
2025-06-04
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,440
Brno, Ostrava - Poruba, Prague, Olomouc
2025-05-13
Recruiting
Hoffmann-La Roche
Phase 3
425
Hradec Králové, Ostrava - Poruba, Prague, Ústí nad Labem
2025-05-12
Recruiting
Incyte Corporation
Phase 3
600
Ostrava-poruba, Prague, Praha 13-stodulky
2025-02-28
Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
NCT06564038Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma
AstraZeneca
Phase 1/2
408
Ostrava - Poruba, Prague, Praha 2 - Nové Město
2025-01-30
Recruiting
Pfizer
Phase 3
900
Ostrava - Poruba, Olomouc, Pardubice, Prague, Liberec
2024-10-22
Active, closed
Vor Biopharma
Phase 3
191
Ostrava-Poruba, Brno
2024-07-17
Active, closed
Janssen Research & Development, LLC
Phase 2
333
Brno-Bohunice, Hradec Králové, Olomouc, Ostrava - Poruba, Prague
2024-05-30
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
Brno, Kyjov, Ostrava-Poruba
2024-05-20
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
Sanofi
Phase 3
2,500
Brno, Hradec Králové, Jihlava, Ostrava - Poruba, Pardubice, Prague, Praha 5 - Motol, Teplice
2024-04-16
Active, closed
Takeda
Phase 2
213
Hořovice, Brno, Hradec Králové, Ostrava, Ostrava-Poruba, Pardubice, Prague, Ústí nad Labem
2024-03-29
Recruiting
Takeda
Phase 2
268
Hořovice, Brno, České Budějovice, Hradec Králové, Ostrava, Ostrava-Poruba, Pardubice, Prague
2024-03-05
Recruiting
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
NCT06072482Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Amgen
Phase 4
300
Hradec Králové, Olomouc, Ostrava - Poruba, Pilsen, Prague
2024-02-07
Active, closed
Incyte Corporation
Phase 3
617
Ostrava - Poruba, Prague
2024-01-30
Active, closed
Ipsen
Phase 3
759
Brno, Hradec Králové, Jihlava, Ostrava - Poruba, Prague
2023-10-12
Active, closed
Bristol-Myers Squibb
Phase 3
579
Prague, Hradec Králové, Olomouc, Ostrava Poruba
2023-03-06
Recruiting
Anthos Therapeutics, Inc.
Phase 3
2,500
Brandýs nad Labem, Liberec, Ostrava - Poruba, Poděbrady, Prague, Trutnov, Ústí nad Labem
2022-12-27
Recruiting
Study Comparing Transobturator Cystocele vs. Anterior Vaginal RepairS
NCT05602246Pelvic Organ Prolapse, Cystocele, Cystocele and Incomplete Uterovaginal Prolapse
Charles University, Czech Republic
Not applicable
592
Hradec Králové, Ostrava-Poruba, Pardubice, Pilsen, Prague, Zlín
2022-12-01
Active, closed
AstraZeneca
Phase 3
607
Hradec Králové, Ostrava - Poruba, Pilsen
2022-09-12
Active, closed
Shanghai Henlius Biotech
Phase 3
511
Brno, Olomouc, Ostrava-Poruba, Ostrava-Vitkovice, Ostrava-Vítkovice, Prague
2022-05-17
Active, closed
Pierre Fabre Medicament
Phase 3
815
Hradec Králové, Olomouc, Ostrava - Poruba, Prague
2022-05-02
By invitation
UCB Biopharma SRL
Phase 3
300
Brno, Ostrava - Poruba, Prague
2022-02-03
Recruiting
UCB Biopharma SRL
Phase 3
350
Brno, Ostrava - Poruba, Prague
2021-12-07
Recruiting
Pfizer
Phase 3
893
Brno, Plzen - Lochotin, Prague, Hradec Králové, Olomouc, Ostrava-Poruba
2021-10-04
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Brno, Bruntál, České Budějovice, Hradec Králové, Jihlava, Liberec, Ostrava - Poruba, Pardubice
2021-08-14
Active, closed
HUYABIO International, LLC.
Phase 3
450
Olomouc, Ostrava-Poruba, Prague
2021-08-12
Active, closed
Sanofi
Phase 2
129
Brno, Hradec Králové, Jihlava, Ostrava - Poruba, Teplice
2021-06-07
Active, closed
Pfizer
Phase 3
599
Olomouc, Ostrava - Poruba, Prague, Praha 8- Liben
2021-05-12
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
281
Ostrava Poruba, Prague
2020-11-03
Active, closed
Genmab
Phase 1/2
543
Hradec Králové, Ostrava - Poruba, Prague
2020-11-03
Active, closed
Acerta Pharma BV
Phase 3
611
Brno, Hradec Králové, Ostrava - Poruba, Pilsen, Prague
2020-10-08
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
125
Ostrava - Poruba, Prague
2020-08-25
Active, closed
AstraZeneca
Phase 3
185
Brno, Olomouc, Ostrava Poruba, Prague
2020-08-04
Active, closed
Sanofi
Phase 3
337
Brno, Hradec Králové, Olomouc, Ostrava - Poruba, Prague
2020-06-16
Active, closed
Bristol-Myers Squibb
Phase 3
790
Prague, Ostrava-Poruba
2019-10-28
Active, closed
Pfizer
Phase 3
896
Brno, Hradec Králové, Klatovy, Olomouc, Ostrava-Poruba, Prague, Slaný
2019-09-05
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Brno, Hradec Králové, Olomouc, Ostrava-Poruba, Prague
2019-08-09
Active, closed
Sanofi
Observational
955
Hradec Králové, Olomouc, Ostrava - Poruba, Pilsen, Prague, Ústí nad Labem
2019-06-11
Active, closed
Acerta Pharma BV
Phase 3
984
Brno, Hradec Králové, Olomouc, Ostrava - Poruba, Plzen - Lochotin, Prague
2019-02-25
Recruiting
Martin Schrappe
Phase 3
5,000
Brno, České Budějovice, Hradec Králové, Olomouc, Ostrava-Poruba, Pilsen, Prague, Ústí nad Labem
2018-07-15
Active, closed
Hoffmann-La Roche
Phase 3
927
Jihlava, Olomouc, Ostrava-Poruba, Prague
2018-05-28
Active, closed
Centre Hospitalier Universitaire de Besancon
Not applicable
989
Olomouc, Ostrava-Poruba, Prague
2018-05-03
Active, closed
Pfizer
Phase 3
1,054
Hradec Králové, Ostrava-Poruba, Pardubice, Prague
2017-12-18
Active, closed
Acerta Pharma BV
Phase 3
635
Brno, Hradec Králové, Ostrava Poruba, Pilsen, Prague
2017-04-05
Active, closed
Acerta Pharma BV
Phase 3
310
Brno, Nový Hradec Králové, Olomouc, Ostrava Poruba, Plzen - Lochotin, Prague
2017-02-02
Rows per page Showing 1–72 of 72
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Czech investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 November 2026. https://priyalifescience.com/clinical-trials-czechia/city/ostrava-poruba

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Czechia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,522 studies in total at the last sync on 14 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 72 of those studies with a site in Ostrava-Poruba.

How many clinical trials are recruiting in Ostrava-Poruba?

30 of the 72 studies on this page are recruiting new participants as of the 14 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 40 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ostrava-Poruba), 72 studies
PhaseStudiesRecruitingShare
Phase 3562177.8%
Phase 28511.1%
Not applicable324.2%
Phase 1/2314.2%
Observational101.4%
Phase 4111.4%

Most active sponsors

Lead sponsors with the most studies (Ostrava-Poruba)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC62
Pfizer62
Merck Sharp & Dohme LLC55
Sanofi50
Acerta Pharma BV40
Amgen42
Incyte Corporation42
AstraZeneca31
Bristol-Myers Squibb31
Celgene30
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.